Breathing life into BMY's reject

York Medical Inc. is going to get a chance to see if it has better instincts than Bristol-Meyers Squibb Corp. York has acquired from the University of Manitoba and CancerCare Manitoba exclusive rights to a small molecule chemopotentiator,

Read the full 384 word article

How to gain access

Continue reading with a
two-week free trial.